Safety and efficacy of cidofovir for adenovirus infectio
Not Applicable
Completed
- Conditions
- adenovirus infection
- Registration Number
- JPRN-UMIN000004336
- Lead Sponsor
- Hematology, Osaka City University, Graduate School of Meicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects who meet any of the following criteria are not eligible. 1) Positive for anti-HIV antibody 2) Positive for hepatitis B surface antigen or HBV-DNA 3) Positive for anti-HCV antibody 4) Creatinine clearance lower than 0.1ml/min/kg calculated by the Cockcroft-Gault formula 5) Patients who have coexisting sinusoidal obstruction syndrome 6) Known hypersensitivity to cidofovir 7) Known hypersensitivity to probenecid 8) Patients who are ineligible for this study as judged by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method